title: Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
abstract: We describe two patients with liver kidney microsomal antibody type 1 (LKM1)-positive autoimmune hepatitis (AIH) with associated endocrinopathies. The first patient had insulin-dependent diabetes (IDDM), and the second patient had Addison's disease and hypoparathyroidism, and is also positive for islet cell antibodies, without overt diabetes. To account for the existence of multiple endocrinopathy in these patients, we investigated whether there is sequence similarity between the target of LKM1 antibodies, cytochrome P4502D6 (CYP2D6), and other human proteins, and if so, whether this structural similarity produces a detectable cross-reactive immune response. Our database search identified two proteins, carboxypeptidase H, an autoantigen in insulin-dependent diabetes, and 21-hydroxylase, the major autoantigen in Addison's disease, that share sequence similarity to the second major LKM1 epitope on CYP2D6. We tested the reactivity of sera from these patients to the homologous regions of the three autoantigens using an enzyme-linked immunosorbent assay (ELISA). The cut-off for positivity was established by testing sera from 22 healthy children. To determine the significance of reactivity to the peptide homologues of the three autoantigens, we investigated 16 additional patients with LKM1 AIH and 20 children with chronic hepatitis B virus infection as pathological controls. We found that reactivity to the second major epitope of CYP2D6 is significantly associated with reactivity to the homologous regions of carboxypeptidase H (CPH) and 21-hydroxylase (21-OHase) in patients with LKM1 AIH, and that this simultaneous recognition is cross-reactive. We suggest that a cross-reactive immune response between homologous autoantigens may contribute to the development of multiple endocrinopathies in LKM1 AIH.
authors.affiliation: Department of Child Health, King's College School of Medicine, London, England.
authors.forename: K
authors.initials: K
authors.lastname: Choudhuri
authors.forename: G V
authors.initials: GV
authors.lastname: Gregorio
authors.forename: G
authors.initials: G
authors.lastname: Mieli-Vergani
authors.forename: D
authors.initials: D
authors.lastname: Vergani
mesh_terms: D000595:Amino Acid Sequence; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology*; D043423:Carboxypeptidase H; D002268:Carboxypeptidases / Q000737:chemistry / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D019389:Cytochrome P-450 CYP2D6 / Q000737:chemistry / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006509:Hepatitis B / Q000276:immunology; D019693:Hepatitis, Autoimmune / Q000276:immunology*; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D017385:Sequence Homology; D013255:Steroid 21-Hydroxylase / Q000737:chemistry / Q000276:immunology
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; C060729:anti-liver kidney microsome antibody; D019389:Cytochrome P-450 CYP2D6; D013255:Steroid 21-Hydroxylase; D002268:Carboxypeptidases; D043423:Carboxypeptidase H